Advocate

RSS

imidacloprid / moxidectin

Authorised
This medicine is authorised for use in the European Union.

Overview

Advocate is a medicine used on cats, ferrets and dogs suffering from, or at risk from, mixed parasitic infections (caused by several different types of parasites):

  • for the treatment and prevention of flea infestations in cats, ferrets and dogs;
  • as part of treatment strategies for flea allergy dermatitis (an allergic reaction to flea bites) in cats and dogs;
  • for the treatment of ear mite infestations in cats and dogs;
  • for the treatment of notoedric mange in cats;
  • for the treatment of biting lice infestations in dogs;
  • for the treatment of skin diseases in dogs caused by parasitic mites (sarcoptic mange and demodicosis);
  • for the prevention of heartworm disease (infection with Dirofilaria immitis) in cats, ferrets and dogs;
  • for the prevention and treatment of skin worm (infection with Dirofilaria repens) in dogs;
  • for the prevention and treatment of lungworm in cats and dogs;
  • for the prevention of spirocercosis (a worm infection affecting the gullet) in dogs;
  • for the treatment of nasal worm in dogs;
  • for the treatment of eye worm in cats and dogs;
  • for the treatment of infections with certain gastrointestinal roundworms, hookworms and whipworms in cats and dogs.

It contains two active substances, imidacloprid and moxidectin. 
 

This EPAR was last updated on 11/09/2019

Authorisation details

Product details
Name
Advocate
Agency product number
EMEA/V/C/000076
Active substance
  • imidacloprid
  • moxidectin
International non-proprietary name (INN) or common name
imidacloprid / moxidectin
Species
  • Dogs
  • Cats
  • Ferrets
Anatomical therapeutic chemical veterinary (ATCvet) codes
QP54AB52
Publication details
Marketing-authorisation holder
Bayer Animal Health GmbH
Revision
20
Date of issue of marketing authorisation valid throughout the European Union
02/04/2003
Contact address
51368 Leverkusen
Germany

Product information

29/07/2019 Advocate - EMEA/V/C/000076 - II/0041/G

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS

Therapeutic indication

Dogs

For dogs suffering from, or at risk from, mixed parasitic infections:

  • the treatment and prevention of flea infestation (Ctenocephalides felis),
  • the treatment of biting lice (Trichodectes canis),
  • the treatment of ear mite infestation (Otodectes cynotis), sarcoptic mange (caused by Sarcoptes scabiei var. canis), demodicosis (caused by Demodex canis),
  • the prevention of heartworm disease (L3 and L4 larvae of Dirofilaria immitis),
  • the treatment of circulating microfilariae (Dirofilaria immitis),
  • the treatment of cutaneous dirofilariosis (adult stages of Dirofilaria repens)
  • the prevention of cutaneous dirofilariosis (L3 larvae of Dirofilaria repens),
  • the reduction of circulating microfilariae (Dirofilaria repens),
  • the prevention of angiostrongylosis (L4 larvae and immature adults of Angiostrongylus vasorum),
  • the treatment of Angiostrongylus vasorum and Crenosoma vulpis,
  • the prevention of spirocercosis (Spirocerca lupi),
  • the treatment of Eucoleus (syn. Capillaria) boehmi (adults),
  • the treatment of the eye worm Thelazia callipaeda (adults),
  • the treatment of infections with gastrointestinal nematodes (L4 larvae, immature adults and adults of Toxocara canis, Ancylostoma caninum and Uncinaria stenocephala, adults of Toxascaris leonina and Trichuris vulpis).

The product can be used as part of a treatment strategy for flea allergy dermatitis (FAD).

Cats

For cats suffering from, or at risk from, mixed parasitic infections:

  • the treatment and prevention of flea infestation (Ctenocephalides felis),
  • the treatment of ear mite infestation (Otodectes cynotis),
  • the treatment of notoedric mange (Notoedres cati),
  • the treatment of the lungworm Eucoleus aerophilus (syn. Capillaria aerophila) (adults),
  • the prevention of lungworm disease (L3/L4 larvae of Aelurostrongylus abstrusus),
  • the treatment of the lungworm Aelurostrongylus abstrusus (adults),
  • the treatment of the eye worm Thelazia callipaeda (adults),
  • the prevention of heartworm disease (L3 and L4 larvae of Dirofilaria immitis),
  • the treatment of infections with gastrointestinal nematodes (L4 larvae, immature adults and adults of Toxocara cati and Ancylostoma tubaeforme).

The product can be used as part of a treatment strategy for flea allergy dermatitis (FAD).

Ferrets

For ferrets suffering from, or at risk from, mixed parasitic infections:

  • the treatment and prevention of flea infestation (Ctenocephalides felis),
  • the prevention of heartworm disease (L3 and L4 larvae of Dirofilaria immitis).

Assessment history

Changes since initial authorisation of medicine

How useful was this page?

Add your rating
Average
2 ratings
1 rating